Alzheimer Disease Clinical Trials in San Francisco, California

3 studies are recruiting for alzheimer disease in San Francisco, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Alzheimer's Tau Platform: Master Protocol

    The goal of the Alzheimer's Tau Platform (ATP) is to evaluate the safety and effectiveness of tau-directed therapies, alone or in combination with the anti-amyloid monoclonal antibody, donanemab, in adults aged 50-80 with late preclinical or early prodromal Alzheimer's disease. This platform trial …

    Stage
    Phase 2
    Ages
    50 to 80
    Site
    University of California, San Francisco, San Francisco, California
    Locations
    3 in total
    Run by
    Paul S. Aisen
  2. [18F]PI-2620 Phase 3 Histopathological Study

    This study is an open-label, multi-center, non-randomized pivotal Phase 3 study to assess the efficacy and safety of PET imaging with [18F]PI-2620 for detection of tau deposition in subjects with Alzheimer's disease (AD) and controls during lifetime when compared to histopathology obtained after de…

    Stage
    Phase 3
    Ages
    50 and older
    Site
    Sutter Health, San Francisco, California
    Locations
    25 in total
    Run by
    Lantheus Biosciences Ltd.
  3. First-in-Human Evaluation of an Astrocytic Glutamate Transporter (EAAT2) PET Tracer in Dementia

    This is a first in human study that will assess the safety and diagnostic performance of [18F]RP-115 (fluorine-18 labeled RP115), a positron emission tomography (PET) agent. This agent has the potential to identify the early changes that occur in the brains of patients with Alzheimer's disease (AD)…

    Stage
    Phase 1
    Ages
    40 to 75
    Site
    China Basin, UCSF, San Francisco, California
    Run by
    David Wilson

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.